▶ 調査レポート

世界の医師調剤薬用化粧品市場2021年ー2031年:製品種類別(フェイスケア、スキンケア)、用途別

• 英文タイトル:Physician Dispensed Cosmeceuticals Market (Product Type: Face-care and Skincare; and Application: Skin Lightening or De-pigmenting, Rhytide Reduction, Anti-wrinkle/Aging, Scar-reducing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Physician Dispensed Cosmeceuticals Market (Product Type: Face-care and Skincare; and Application: Skin Lightening or De-pigmenting, Rhytide Reduction, Anti-wrinkle/Aging, Scar-reducing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031「世界の医師調剤薬用化粧品市場2021年ー2031年:製品種類別(フェイスケア、スキンケア)、用途別」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2204B005
• 出版社/出版日:Transparency Market Research / 2022年4月20日
• レポート形態:英文、PDF、177ページ
• 納品方法:Eメール
• 産業分類:消費財
• 販売価格(消費税別)
  Single User¥799,710 (USD5,795)▷ お問い合わせ
  Multi User¥1,213,710 (USD8,795)▷ お問い合わせ
  Corporate License¥1,627,710 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本市場調査資料では、世界の医師調剤薬用化粧品市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別(フェイスケア、スキンケア)分析、疾患別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめました。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の医師調剤薬用化粧品市場規模:製品種類別(フェイスケア、スキンケア)
・世界の医師調剤薬用化粧品市場規模:疾患別
・世界の医師調剤薬用化粧品市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

TMR’s report on the global physician dispensed cosmeceuticals market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global physician dispensed cosmeceuticals market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global physician dispensed cosmeceuticals market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global physician dispensed cosmeceuticals market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global physician dispensed cosmeceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global physician dispensed cosmeceuticals market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global physician dispensed cosmeceuticals market.

The report delves into the competitive landscape of the global physician dispensed cosmeceuticals market. Key players operating in the global physician dispensed cosmeceuticals market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global physician dispensed cosmeceuticals market that have been profiled in this report.

Key Questions Answered in Physician Dispensed Cosmeceuticals Market Report
What is the scope of growth of product companies in the global physician dispensed cosmeceuticals market?
What will be the Y-o-Y growth of the global physician dispensed cosmeceuticals market between 2019 and 2031?
What is the influence of changing trends in technologies on the global physician dispensed cosmeceuticals market?
Will North America continue to be the most profitable market for physician dispensed cosmeceuticals providers?
Which factors are anticipated to hamper the growth of the global physician dispensed cosmeceuticals market during the forecast period?
Which are the leading companies in the global physician dispensed cosmeceuticals market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global physician dispensed cosmeceuticals market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global physician dispensed cosmeceuticals market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the physician dispensed cosmeceuticals market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the physician dispensed cosmeceuticals market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global physician dispensed cosmeceuticals market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global physician dispensed cosmeceuticals market more reliably and accurately.

Physician Dispensed Cosmeceuticals Market – Segmentation

*** Product Type
Face-care
Skincare

*** Application
Skin Lightening or De-pigmenting
Rhytide Reduction
Anti-wrinkle / Aging
Scar-reducing
Others

*** Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market

4. Market Overview

4.1. Introduction

4.1.1. Product Type Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, 2017–2031

5. Key Insights

5.1. Product/ Brand Analysis

5.2. Key Mergers & Acquisitions

5.3. Regulatory Scenario by Region/globally

5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product Type, 2017–2031

6.3.1. Face-care

6.3.2. Skincare

6.4. Market Attractiveness Analysis, by Product Type

7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Indication

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Indication, 2017–2031

7.3.1. Skin Lightening or De-pigmenting

7.3.2. Rhytide Reduction

7.3.3. Anti-wrinkle/Aging

7.3.4. Scar-reducing

7.3.5. Others

7.4. Market Attractiveness Analysis, by Indication

8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Region

9. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast, by Product Type, 2017–2031

9.2.1. Face-care

9.2.2. Skincare

9.3. Market Value Forecast, by Indication, 2017–2031

9.3.1. Skin Lightening or De-pigmenting

9.3.2. Rhytide Reduction

9.3.3. Anti-wrinkle/Aging

9.3.4. Scar-reducing

9.3.5. Others

9.4. Market Value Forecast, by Country, 2017–2031

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Product Type

9.5.2. By Indication

9.5.3. By Country

10. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Product Type, 2017–2031

10.2.1. Face-care

10.2.2. Skincare

10.3. Market Value Forecast, by Indication, 2017–2031

10.3.1. Skin Lightening or De-pigmenting

10.3.2. Rhytide Reduction

10.3.3. Anti-wrinkle/Aging

10.3.4. Scar-reducing

10.3.5. Others

10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Rest of Europe

10.5. Market Attractiveness Analysis

10.5.1. By Product Type

10.5.2. By Indication

10.5.3. By Country/Sub-region

11. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Product Type, 2017–2031

11.2.1. Face-care

11.2.2. Skincare

11.3. Market Value Forecast, by Indication, 2017–2031

11.3.1. Skin Lightening or De-pigmenting

11.3.2. Rhytide Reduction

11.3.3. Anti-wrinkle/Aging

11.3.4. Scar-reducing

11.3.5. Others

11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Market Attractiveness Analysis

11.5.1. By Product Type

11.5.2. By Indication

11.5.3. By Country/Sub-region

12. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Product Type, 2017–2031

12.2.1. Face-care

12.2.2. Skincare

12.3. Market Value Forecast, by Indication, 2017–2031

12.3.1. Skin Lightening or De-pigmenting

12.3.2. Rhytide Reduction

12.3.3. Anti-wrinkle/Aging

12.3.4. Scar-reducing

12.3.5. Others

12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Market Attractiveness Analysis

12.5.1. By Product Type

12.5.2. By Indication

12.5.3. By Country/Sub-region

13. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Product Type, 2017–2031

13.2.1. Face-care

13.2.2. Skincare

13.3. Market Value Forecast, by Indication, 2017–2031

13.3.1. Skin Lightening or De-pigmenting

13.3.2. Rhytide Reduction

13.3.3. Anti-wrinkle/Aging

13.3.4. Scar-reducing

13.3.5. Others

13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Market Attractiveness Analysis

13.5.1. By Product Type

13.5.2. By Indication

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player – Competition Matrix (by tier and size of companies)

14.2. Company Profiles

14.2.1. AbbVie Inc. (Allergan)

14.2.1.1. Company Overview

14.2.1.2. Financial Overview

14.2.1.3. Product Portfolio

14.2.1.4. SWOT Analysis

14.2.1.5. Strategic Overview

14.2.2. L’Oreal S.A.

14.2.2.1. Company Overview

14.2.2.2. Financial Overview

14.2.2.3. Product Portfolio

14.2.2.4. SWOT Analysis

14.2.2.5. Strategic Overview

14.2.3. Jan Marini Skin Research, Inc.

14.2.3.1. Company Overview

14.2.3.2. Financial Overview

14.2.3.3. Product Portfolio

14.2.3.4. SWOT Analysis

14.2.3.5. Strategic Overview

14.2.4. Athena Cosmetics, Inc.

14.2.4.1. Company Overview

14.2.4.2. Financial Overview

14.2.4.3. Product Portfolio

14.2.4.4. SWOT Analysis

14.2.4.5. Strategic Overview

14.2.5. ZO Skin Health Inc.

14.2.5.1. Company Overview

14.2.5.2. Financial Overview

14.2.5.3. Product Portfolio

14.2.5.4. SWOT Analysis

14.2.5.5. Strategic Overview

14.2.6. Galderma Laboratories, L.P.

14.2.6.1. Company Overview

14.2.6.2. Financial Overview

14.2.6.3. Product Portfolio

14.2.6.4. SWOT Analysis

14.2.6.5. Strategic Overview

14.2.7. Procter & Gamble Co.

14.2.7.1. Company Overview

14.2.7.2. Financial Overview

14.2.7.3. Product Portfolio

14.2.7.4. SWOT Analysis

14.2.7.5. Strategic Overview

14.2.8. The Estée Lauder Companies, Inc.

14.2.8.1. Company Overview

14.2.8.2. Financial Overview

14.2.8.3. Product Portfolio

14.2.8.4. SWOT Analysis

14.2.8.5. Strategic Overview

14.2.9. Merz Pharma

14.2.9.1. Company Overview

14.2.9.2. Financial Overview

14.2.9.3. Product Portfolio

14.2.9.4. SWOT Analysis

14.2.9.5. Strategic Overview

14.2.10. Obagi Cosmeceuticals LLC

14.2.10.1. Company Overview

14.2.10.2. Financial Overview

14.2.10.3. Product Portfolio

14.2.10.4. SWOT Analysis

14.2.10.5. Strategic Overview

14.2.11. iS CLINICAL

14.2.11.1. Company Overview

14.2.11.2. Financial Overview

14.2.11.3. Product Portfolio

14.2.11.4. SWOT Analysis

14.2.11.5. Strategic Overview

14.2.12. Neutrogena

14.2.12.1. Company Overview

14.2.12.2. Financial Overview

14.2.12.3. Product Portfolio

14.2.12.4. SWOT Analysis

14.2.12.5. Strategic Overview

List of Tables

Table 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017‒2031

Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 05: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 06: North America Physician Dispensed Cosmeceuticals Market (US$ Mn) Forecast, by Indication, 2017–2031

Table 07: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 08: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 10: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 11: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 12: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 13: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031

List of Figures

Figure 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Physician Dispensed Cosmeceuticals Market Value Share, by Product Type, 2020

Figure 03: Global Physician Dispensed Cosmeceuticals Market Value Share, by Indication, 2020

Figure 04: Global Physician Dispensed Cosmeceuticals Market Value Share, by Region, 2020

Figure 05: Global Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 06: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 07: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Face-care, 2017–2031

Figure 08: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skincare, 2017–2031

Figure 09: Global Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 10: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 11: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skin Lightening or De-pigmenting, 2017–2031

Figure 12: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Rhytide Reduction, 2017–2031

Figure 13: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Anti-wrinkle/Aging, 2017–2031

Figure 14: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Scar-reducing, 2017–2031

Figure 15: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Others, 2017–2031

Figure 16: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Region, 2020 and 2031

Figure 17: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Region, 2021–2031

Figure 18: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 19: North America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2020 and 2031

Figure 20: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2021–2031

Figure 21: North America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 22: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 23: North America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 24: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 25: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: Europe Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 27: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 28: Europe Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 29: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 30: Europe Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 31: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 32: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 33: Asia Pacific Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 34: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 35: Asia Pacific Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 36: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 37: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 38: Latin America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 39: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 40: Latin America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 41: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 42: Latin America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 43: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031

Figure 44: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031

Figure 45: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 46: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031

Figure 48: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 49: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031

Figure 50: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031